The global medical cannabis market is being driven by the rise in the legalisation of cannabis. North America is the largest market for marijuana, for both medical and recreational uses. The regional market is being aided by the high population density of the areas with legalised medical cannabis as more than 60% of the region’s population reside in these areas. In 2017, nearly 1.9 million people in North America were legally utilising the substance to relieve conditions like chronic pain and polymorphic seizures. In Canada, while the consumption of cannabis for medical purposes has been legal since 2001, in October 2018, the country legalised the substance for recreational use too. Health Canada governs the Canadian medical cannabis industry, and as of September 2017, had 58 licensed cannabis producers, with 167, 754 registered patients in March 2017 using cannabis. Medical marijuana is expected to contribute to nearly 25% of cannabis sales in 2019. Canada is a leading cannabis market, globally, and exports the substance to other major overseas markets like Western Europe.
Get a Free Sample Report With TOC For Market Study - Download Now
The US is also a major global market and is finding impetus for its growth in the increasing legalisation of the substance. Currently, the use of medical marijuana is legal in 33 states and Washington, D.C. The retail sales of medicinal marijuana in the country reached nearly USD 3.7 billion in 2018. While individual states are passing laws legalising cannabis, it is still illegal under federal law. Thus, multiple US companies prefer conducting their research on medical marijuana in countries like Israel, where they are not hindered by federal institutes like the National Institute on Drug Abuse and the Drug Enforcement Agency. Israel is one of the leading regions for cannabis research, and over 50 US companies are undertaking research related to medical cannabis in the country.
Market Breakup by Types, Species, Compounds, Applications, Distribution Channels, and Region:
Key Findings of the Report:
Key Offerings of the Report:
Tilray, Bedrocan International, Canopy Growth Corporation, Aurora Cannabis Inc., Aphria Inc., Terra Tech Corp., Vivo Cannabis Inc., Emerald Health Therapeutics, Inc, Cronos Group Inc, and Organigram Holdings Inc, among others are the major players in the global medical cannabis market. The comprehensive report looks into their capacity, market share, and latest developments like merger and acquisitions, capacity expansions, and plant turnarounds.
EMR is a leading business intelligence firm, providing custom and syndicated market reports along with consultancy services for our clients. We serve a wide client base ranging from Fortune 1000 companies to small and medium enterprises. Our reports cover over 100 industries across established and emerging markets researched by our skilled analysts who track the latest economic, demographic, trade and market data globally.
At EMR, we tailor our approach according to our clients’ needs and preferences, providing them with valuable, actionable and up-to-date insights into the market, thus, helping them realize their optimum growth potential. We offer market intelligence across a range of industry verticals which include Pharmaceuticals, Food and Beverage, Technology, Retail, Chemical and Materials, Energy and Mining, Packaging and Agriculture.
EMR Business Solutions LLP
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790
"Global Medical Cannabis Market: By Product: Dried and Extract Form; By Species: Indica, Sativa and Hybrid; By Compound: THC-Dominant, CBD-Dominant, Balanced THC & CBD; By Application: Pain Management, Seizure and Others; By Region: North America, Europe, Asia Pacific, LATAM, Middle East & Africa; SWOT Analysis; Historical Production and Consumption (2015-2019); Production and Consumption Forecast (2020-2025); Competitive Landscape"
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Cannabis refers to a psychoactive medication extracted from the Cannabaceae family cannabis plant. The drug was used in ancient Indian, Chinese, Egyptian as well as Islamic cultures. These days, canna...
The global tumour necrosis factor inhibitor drugs market attained a value of around USD 40.3 billion in 2019. The market is further expected to grow in the forecast period of 2020-2025 at a CAGR of ar...
The global uveitis drugs market is estimated to grow at a CAGR of almost 6.8% in the forecast period of 2020-2025. The global uveitis drugs market is being driven by the increased prevalence of eye di...
The global obsessive-compulsive disorder drugs market is projected to grow at a CAGR of almost 4.8% over the forecast period of 2020-2025. The global obsessive-compulsive disorder drugs market is bein...
The global sinusitis drugs market is expected to grow in the forecast period of 2020-2025 at a CAGR of more than 5.5%. The prevalence of sinus infection among adults and children is growing. Among the...
Buy Full Version
"Medical Cannabis Market" Purchase Enquiry